Загрузка...
Redirecting T cells to hematological malignancies with bispecific antibodies
There is a need to improve outcomes for patients with recurrent and/or refractory hematological malignancies. Immunotherapy holds the promise to meet this need, because it does not rely on the cytotoxic mechanism of conventional therapies. Among different forms of immunotherapy, redirecting T cells...
Сохранить в:
| Опубликовано в: : | Blood |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755042/ https://ncbi.nlm.nih.gov/pubmed/29118005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-06-741058 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|